Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: Effectiveness, benefit harm and cost effectiveness of colorectal cancer screening in Austria

Fig. 2

Cost effectiveness of colorectal screening strategies. Blue cross - No Screening, red circle - colonoscopy, purple square - gFOBT, green triangle - FIT. D - dominated, ICER - incremental cost-effectiveness ratio, gFOBT - guaiac-fecal occult blood test screening strategy, FIT - fecal immunochemical test screening strategy, EUR - Euro, LYG - life-years gained, FIT and gFOBT: 40–75 years old average-risk men and women, annual. Colonoscopy: 50–70 years old average-risk men and women, 10-yearly. All screening strategies include index testing, further diagnostics (including colonoscopy), surveillance (colonoscopy), treatment and follow up interventions. Base-case analysis: assumes full participation and adherence

Back to article page